Influence of Low Doses of Naloxone on Pituitary Secretion in Man

Overview

Journal Eur J Clin Pharmacol

Specialty Pharmacology

Date 1982 Jan 1

PMID 6809476

Citations 1

Authors

E Rolandi

A Marabini

G Magnani

A Sannia

T Barreca

Affiliations

Soon will be listed here.

Abstract

Naloxone 0.8 mg im administered to eight healthy subjects did not affect the serum levels of GH, LH, FSH, PRL, TSH and cortisol. Pretreatment with naloxone 0.8 mg increased TRH-induced TSH and PRL release in six healthy subjects. The same pretreatment caused an enhancement of haloperidol-induced PRL secretion in further other group of six subjects.

Citing Articles

Serum concentrations of PRL, GH, LH, FSH, TSH and cortisol after single administration to man of a new synthetic narcotic analgesic butorphanol.

Rolandi E, Franceschini R, Marabini A, Messina V, Barreca T Eur J Clin Pharmacol. 1984; 26(5):563-5.

PMID: 6432552 DOI: 10.1007/BF00543485.

References

Volavka J, Cho D, Mallya A, Bauman J . Naloxone increases ACTH and cortisol levels in man. N Engl J Med. 1979; 300(18):1056-7. DOI: 10.1056/nejm197905033001817. View

MOLINATTI G, MASSARA F, STRUMIA E, Pennisi F, SCASSELLATI G, Vancheri L . Radioimmunoassay of human growth hormone. J Nucl Biol Med. 1969; 13(1):26-36. View

Meites J, Bruni J, Van Vugt D, Smith A . Relation of endogenous opioid peptides and morphine to neuroendocrine functions. Life Sci. 1979; 24(15):1325-36. DOI: 10.1016/0024-3205(79)90001-8. View

Morley J, Baranetsky N, Wingert T, Carlson H, Hershman J, Melmed S . Endocrine effects of naloxone-induced opiate receptor blockade. J Clin Endocrinol Metab. 1980; 50(2):251-7. DOI: 10.1210/jcem-50-2-251. View

Spiler I, Molitch M . Lack of modulation of pituitary hormone stress response by neural pathways involving opiate receptors. J Clin Endocrinol Metab. 1980; 50(3):516-20. DOI: 10.1210/jcem-50-3-516. View

Wakabayashi I, DEMURA R, Miki N, Ohmura E, Miyoshi H, SHIZUME K . Failure of naloxone to influence plasma growth hormone, prolactin, and cortisol secretions induced by insulin hypoglycemia. J Clin Endocrinol Metab. 1980; 50(3):597-9. DOI: 10.1210/jcem-50-3-597. View

Ruder H, Guy R, LIPSETT M . A radioimmunoassay for cortisol in plasma and urine. J Clin Endocrinol Metab. 1972; 35(2):219-24. DOI: 10.1210/jcem-35-2-219. View

Quigley M, Sheehan K, Casper R, Yen S . Evidence for an increased opioid inhibition of luteinizing hormone secretion in hyperprolactinemic patients with pituitary microadenoma. J Clin Endocrinol Metab. 1980; 50(3):427-30. DOI: 10.1210/jcem-50-3-427. View

Grossman A, Moult P, Gaillard R, Delitala G, Toff W, Rees L . The opioid control of LH and FSH release: effects of a met-enkephalin analogue and naloxone. Clin Endocrinol (Oxf). 1981; 14(1):41-7. DOI: 10.1111/j.1365-2265.1981.tb00363.x. View

10.

Sinha Y, SELBY F, Lewis U, VANDERLAAN W . A homologous radioimmunoassay for human prolactin. J Clin Endocrinol Metab. 1973; 36(3):509-16. DOI: 10.1210/jcem-36-3-509. View

11.

Dupont A, Cusan L, Labrie F, Coy D, Li C . Stimulation of prolactin release in the rat by intraventricular injection of beta-endorphin and methionine-enkephalin. Biochem Biophys Res Commun. 1977; 75(1):76-82. DOI: 10.1016/0006-291x(77)91291-8. View

12.

Rivier C, Vale W, Ling N, Brown M, Guillemin R . Stimulation in vivo of the secretion of prolactin and growth hormone by beta-endorphin. Endocrinology. 1977; 100(1):238-41. DOI: 10.1210/endo-100-1-238. View

13.

Midgley A . Radioimmunoassay for human follicle-stimulating hormone. J Clin Endocrinol Metab. 1967; 27(2):295-9. DOI: 10.1210/jcem-27-2-295. View

14.

Bruni J, van Vugt D, Marshall S, Meites J . Effects of naloxone, morphine and methionine enkephalin on serum prolactin, luteinizing hormone, follicle stimulating hormone, thyroid stimulating hormone and growth hormone. Life Sci. 1977; 21(3):461-6. DOI: 10.1016/0024-3205(77)90528-8. View

15.

Chihara K, Arimura A, Coy D, Schally A . Studies on the interaction of endorphins, substance P. and endogenous somatostatin in growth hormone and prolactin release in rats. Endocrinology. 1978; 102(1):281-90. DOI: 10.1210/endo-102-1-281. View

16.

von Graffenried B, Del Pozo E, Roubicek J, Krebs E, Poldinger W, Burmeister P . Effects of the synthetic enkephalin analogue FK 33-824 in man. Nature. 1978; 272(5655):729-30. DOI: 10.1038/272729a0. View

17.

Blankstein J, Reyes F, Winter J, Faiman C . Failure of naloxone to alter growth hormone and prolactin levels in acromegalic and in hyperprolactinaemic patients. Clin Endocrinol (Oxf). 1979; 11(5):475-9. DOI: 10.1111/j.1365-2265.1979.tb03099.x. View

18.

Odell W, Wilber J, Paul W . Radioimmunoassay of thyrotropin in human serum. J Clin Endocrinol Metab. 1965; 25(9):1179-88. DOI: 10.1210/jcem-25-9-1179. View

19.

Lee S, Panerai A, BELLABARBA D, Friesen H . Effect of endocrine modifications and pharmacological treatments on brain and pituitary concentrations of beta-endorphin. Endocrinology. 1980; 107(1):245-8. DOI: 10.1210/endo-107-1-245. View

20.

MIDGLEY Jr A . Radioimmunoassay: a method for human chorionic gonadotropin and human luteinizing hormone. Endocrinology. 1966; 79(1):10-8. DOI: 10.1210/endo-79-1-10. View